P-131 - EXPLORATORY PHARMACOGENETIC STUDY IN HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) RECIPIENTS RECEIVING CYP2C19-GUIDED VORICONAZOLE (VCZ) DOSING.

J. Patel, M. Robinson, E. Jandrisevits, K. Eboli-Lopes, S. Morris, A. Hamilton, M. Smith, N. Steuerwald, B. Avalos, E. Copelan; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.